AI Article Synopsis
- * Methods: Researchers created HKe3 cells with normal (wt) or mutated (mt) KRAS by using retroviral infection and cultured them in a specialized 3D format to monitor their behavior.
- * Results: The 3D cultures formed distinct spheroids, and only the cells with mutated KRAS showed resistance to cell death, demonstrating that this new system is effective for drug screening related to KRAS.
Article Abstract
Background/aim: Oncogenic mutations in the KRAS gene are critically involved in many human tumors but drugs targeting oncogenic KRAS have not yet been clinically developed. Herein, we established a three-dimensional floating (3DF) culture system for screening drugs that target KRAS-mediated signaling molecules.
Materials And Methods: HKe3 cells, derived from colorectal cancer HCT116 cells and disrupted at mutated (mt) KRAS gene, were infected with a retrovirus expressing wild-type (wt) KRAS or mtKRAS to establish HKe3-derived cells expressing wtKRAS or mtKRAS. Established cells were cultured in 96-well plates with an ultra-low attachment surface and round bottom for 3DF culture.
Results: HKe3-wtKRAS and HKe3-mtKRAS cells in 3DF culture rapidly assembled into respective single spherical structures (spheroids). Furthermore, mtKRAS but not wtKRAS expression inhibited luminal apoptosis in spheroids indicating that the 3DF culture was compatible with the 3D matrigel culture.
Conclusion: This 3DF culture system could be useful for screening drugs that target KRAS-mediated signaling molecules.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!